[1] Guan X, Bu F, Fu Y, et al. Immunogenic peptides putatively from intratumor microbes: Opportunities for colorectal cancer treatment[J]. iScience, 2024, 27:111338. doi:10.1016/j.isci.2024.111338. [2] Wu L, Wu H, Huang F, et al. Mendelian randomiza-tion and bioinformatics unveil potential links between gut microbial genera and colorectal cancer[J]. Front Genet, 2024, 15:1379003. doi:10.3389/fgene.2024.1379003. [3] 龙涛.结直肠癌组织中DDX5表达水平及其与患者预后的相关性[J].现代肿瘤医学,2021,29:1157-1160. doi:10.3969/j.issn.1672-4992.2021.07.012. [4] 张雪,韩晶,周欣亮,等. DUOXA2在结直肠癌组织中表达及其与预后的关联[J].中华肿瘤防治杂志,2021,28:502-507. doi:10.16073/j.cnki.cjcpt.2021.07.04. [5] Liu X, Xie X, Li Q, et al. KIF23 promotes cervical cancer progression via inhibiting NLRP3-mediated pyroptosis[J]. FASEB J, 2024, 38:e23685.doi:10.1096/fj.202400281R. [6] Wu Y, Chen W, Miao H, et al. SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23[J]. BMC Cancer, 2024, 24:210. doi:10.1186/s12885-024-11965-9. [7] 黄瑜,周先果,李学宇,等.驱动蛋白家族成员23对结直肠癌细胞增殖、迁移的影响及其作用机制[J].中国癌症防治杂志,2022,14:611-616. doi:10.3969/j.issn.1674-5671.2022.06.03 [8] 邱文秀,王苗锋.乳腺癌特异基因1在三阴性乳腺癌中的表达与免疫治疗疗效及预后分析[J].中国优生与遗传杂志,2024,32:86-91. doi:10.13404/j.cnki.cjbhh.2024.01.013. [9] He X, Wang J, Zhou R, et al. Kinesin family member 23 exerts a protumor function in breast cancer via stimulation of the Wnt/β-catenin pathway[J]. Toxicol Appl Pharmacol, 2022, 435:115834. doi:10.1016/j.taap.2021.115834. [10] Tang W, Zhang L, Li J, et al. KCNQ1OT1 promotes retinoblastoma progression by targeting miR-339-3p that suppresses KIF23[J]. Int Ophthalmol, 2023, 43:2419-2432. doi:10.1007/s10792-023-02641-1. [11] Bai M, Liu X. Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer[J]. Front Oncol, 2023, 13:1191009. doi:10.3389/fonc.2023.1191009. [12] Ji Z, Mi A, Li M, et al. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in colorectal cancer[J]. J Cancer, 2021, 12:2030-2040. doi:10.7150/jca.51565. |